Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression

V. Ram Peddi, Bradley Marder, Luis Gaite, Jose Oberholzer, Ryan Goldberg, Thomas Pearson, Harold Yang, Lisa Allamassey, Martin Polinsky, Richard N. Formica

Open source

DOI: 10.1097/txd.0000000000001419
Published: 2023-01-06
Container: Transplantation Direct
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/txd.0000000000001419,
  title = {Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression},
  author = {V. Ram Peddi and Bradley Marder and Luis Gaite and Jose Oberholzer and Ryan Goldberg and Thomas Pearson and Harold Yang and Lisa Allamassey and Martin Polinsky and Richard N. Formica},
  year = {2023},
  journal = {Transplantation Direct},
  doi = {10.1097/txd.0000000000001419},
  url = {https://doi.org/10.1097/txd.0000000000001419}
}

RIS

TY  - JOUR
TI  - Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
AU  - V. Ram Peddi
AU  - Bradley Marder
AU  - Luis Gaite
AU  - Jose Oberholzer
AU  - Ryan Goldberg
AU  - Thomas Pearson
AU  - Harold Yang
AU  - Lisa Allamassey
AU  - Martin Polinsky
AU  - Richard N. Formica
PY  - 2023
JO  - Transplantation Direct
DO  - 10.1097/txd.0000000000001419
UR  - https://doi.org/10.1097/txd.0000000000001419
ER  -

APA

Peddi, V. R., Marder, B., Gaite, L., Oberholzer, J., Goldberg, R., Pearson, T., Yang, H., Allamassey, L., Polinsky, M., & Formica, R. N. (2023). Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression. Transplantation Direct. https://doi.org/10.1097/txd.0000000000001419

Source records

crossref · retrieved 2026-09-26T11:01:59.448Z